122 related articles for article (PubMed ID: 9467629)
1. Adverse events after protamine administration in patients undergoing cardiopulmonary bypass: risks and predictors of under-reporting.
Kimmel SE; Sekeres MA; Berlin JA; Goldberg LR; Strom BL
J Clin Epidemiol; 1998 Jan; 51(1):1-10. PubMed ID: 9467629
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for clinically important adverse events after protamine administration following cardiopulmonary bypass.
Kimmel SE; Sekeres MA; Berlin JA; Ellison N; DiSesa VJ; Strom BL
J Am Coll Cardiol; 1998 Dec; 32(7):1916-22. PubMed ID: 9857872
[TBL] [Abstract][Full Text] [Related]
3. Mortality and adverse events after protamine administration in patients undergoing cardiopulmonary bypass.
Kimmel SE; Sekeres M; Berlin JA; Ellison N
Anesth Analg; 2002 Jun; 94(6):1402-8, table of contents. PubMed ID: 12031996
[TBL] [Abstract][Full Text] [Related]
4. Adverse events after protamine administration following cardiopulmonary bypass in infants and children.
Seifert HA; Jobes DR; Ten Have T; Kimmel SE; Montenegro LM; Steven JM; Nicolson SC; Strom BL
Anesth Analg; 2003 Aug; 97(2):383-389. PubMed ID: 12873922
[TBL] [Abstract][Full Text] [Related]
5. Acute reaction to protamine. Its importance to surgeons.
Just-Viera JO; Fischer CR; Gago O; Morris JD
Am Surg; 1984 Jan; 50(1):52-60. PubMed ID: 6607003
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic changes after protamine administration: association with mortality after coronary artery bypass surgery.
Welsby IJ; Newman MF; Phillips-Bute B; Messier RH; Kakkis ED; Stafford-Smith M
Anesthesiology; 2005 Feb; 102(2):308-14. PubMed ID: 15681944
[TBL] [Abstract][Full Text] [Related]
7. Noncardiogenic pulmonary edema associated with protamine administration during coronary artery bypass graft surgery.
Urdaneta F; Lobato EB; Kirby RR; Horrow JC
J Clin Anesth; 1999 Dec; 11(8):675-81. PubMed ID: 10680112
[TBL] [Abstract][Full Text] [Related]
8. Protamine-induced fulminating non-cardiogenic pulmonary edema following cardiopulmonary bypass.
Kindler C; Bircher A; Stulz P
Eur J Cardiothorac Surg; 1996; 10(6):463-6. PubMed ID: 8817145
[TBL] [Abstract][Full Text] [Related]
9. Noncardiogenic pulmonary edema immediately following rapid protamine administration.
Brooks JC
Ann Pharmacother; 1999 Sep; 33(9):927-30. PubMed ID: 10492491
[TBL] [Abstract][Full Text] [Related]
10. A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass.
Pretorius M; Scholl FG; McFarlane JA; Murphey LJ; Brown NJ
Clin Pharmacol Ther; 2005 Nov; 78(5):477-85. PubMed ID: 16321614
[TBL] [Abstract][Full Text] [Related]
11. Heparin removal after cardiopulmonary bypass in a patient with adverse reaction to protamine.
Tevaearai HT; Jegger D; Mueller XM; Horisberger J; von Segesser LK
Thorac Cardiovasc Surg; 1998 Oct; 46(5):303-4. PubMed ID: 9885123
[TBL] [Abstract][Full Text] [Related]
12. Noncardiogenic pulmonary edema and peripheral vascular collapse following cardiopulmonary bypass: rare protamine reaction?
Olinger GN; Becker RM; Bonchek LI
Ann Thorac Surg; 1980 Jan; 29(1):20-5. PubMed ID: 7356803
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of patients at risk for protamine reactions.
Levy JH; Schwieger IM; Zaidan JR; Faraj BA; Weintraub WS
J Thorac Cardiovasc Surg; 1989 Aug; 98(2):200-4. PubMed ID: 2755152
[TBL] [Abstract][Full Text] [Related]
14. [Non-cardiogenic pulmonary edema after extracorporeal circulation: implication of protamine sulfate].
Pajuelo A; Otero C; Jiménez D; Gilsanz FJ; Navarro E; Téllez G; Avello F
Rev Esp Anestesiol Reanim; 1986; 33(3):187-9. PubMed ID: 3738092
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of heparinase I versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass.
Stafford-Smith M; Lefrak EA; Qazi AG; Welsby IJ; Barber L; Hoeft A; Dorenbaum A; Mathias J; Rochon JJ; Newman MF;
Anesthesiology; 2005 Aug; 103(2):229-40. PubMed ID: 16052104
[TBL] [Abstract][Full Text] [Related]
16. [Severe shock after protamine infusion in a neonate undergoing cardio pulmonary bypass].
Joram N; Benbrik N; De Windt A; Colas H; Liet JM
Ann Fr Anesth Reanim; 2013 Dec; 32(12):876-8. PubMed ID: 24210577
[TBL] [Abstract][Full Text] [Related]
17. Protamine-associated hypotension in patients on hemodialysis: retrospective study and prevalence of antiprotamine antibodies.
Tsai YT; Chang LC; Lin YF; Tsai CS; Lai CH; Chen JS
Clin Nephrol; 2009 Aug; 72(2):122-8. PubMed ID: 19640369
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgery.
Weiler JM; Gellhaus MA; Carter JG; Meng RL; Benson PM; Hottel RA; Schillig KB; Vegh AB; Clarke WR
J Allergy Clin Immunol; 1990 Apr; 85(4):713-9. PubMed ID: 2182695
[TBL] [Abstract][Full Text] [Related]
19. Successful cardiopulmonary bypass in diabetics with anaphylactoid reactions to protamine.
Walker WS; Reid KG; Hider CF; Davidson IA; Boulton FE; Yap PL
Br Heart J; 1984 Jul; 52(1):112-4. PubMed ID: 6743419
[TBL] [Abstract][Full Text] [Related]
20. Effect of prostaglandin E1 on pulmonary hypertension after protamine injection during cardiac surgery.
Abe K; Sakakibara T; Miyamoto Y; Ohnishi K
Eur J Clin Pharmacol; 1998 Mar; 54(1):21-5. PubMed ID: 9591925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
